ID
45656
Descripción
Principal Investigator: Jeffrey S. Weber, MD, PhD, Donald A. Adam Comprehensive Melanoma Research Center, Moffitt Cancer Center, Tampa, Florida, USA MeSH: Melanoma https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001241 This study contains sequence data from 15 patients with stage IV melanoma, including the whole genome sequence of 15 metastatic tumors and corresponding normal blood samples from 13 cases, and targeted capture sequence of four synchronous metastatic samples from two additional cases. These data provide a comprehensive survey of the clonal architecture and associated driver mutations in metastatic melanoma.
Link
Palabras clave
Versiones (1)
- 21/3/23 21/3/23 - Simon Heim
Titular de derechos de autor
Jeffrey S. Weber, MD, PhD, Donald A. Adam Comprehensive Melanoma Research Center, Moffitt Cancer Center, Tampa, Florida, USA
Subido en
21 de marzo de 2023
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
dbGaP phs001241 Clonal Architectures and Driver Mutations in Metastatic Melanomas
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, and affection status of participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
- Subject ID, sample ID, and sample use variable obtained from participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
- Subject ID, age, and gender of participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
- Sample ID, analyte type, body site where sample was obtained, histological type of sample, and tumor status of sample obtained from participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, and affection status of participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
- Subject ID, sample ID, and sample use variable obtained from participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
- Subject ID, age, and gender of participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
- Sample ID, analyte type, body site where sample was obtained, histological type of sample, and tumor status of sample obtained from participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
C0680251 (UMLS CUI [1,2])
C1706256 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,3])
C1321872 (UMLS CUI [1,4])